Medtech Alliance for Global InternationAlisation
Progetto: Medtech Alliance for Global InternationAlisation
Durata: Project duration: 01/01/2018 – 31/12/2019
MAGIA is the European Strategic Cluster Partnerships – Going International (ESCPs-4i) on medical technologies labelled by the European Commission.
MAGIA is a transnational cluster partnership that develop and implement a joint internationalisation strategy and support SME internationalisation towards third countries beyond Europe.
MAGIA: european partnership to support MedTech SME internationalisation towards third countries beyond Europe
The MAGIA project bring together four European leading Medtech and Health clusters – BioPmed (Piedmont), BioWin (Wallonia), Life Science Nord (Northern Germany) and Lyonbiopole (Auvergne-Rhône-Alpes) – willing to foster and support the Medtech SME internationalisation through the creation of a strong and sustainable Medtech Alliance.
The overall goal of the project is to support the European Medtech SMEs on two target markets and to make the European Medtech industry more visible at the international level.
The global medtech sector can be a tough environment for European small and medium sized enterprises (SMEs) and start-ups. In Europe, this industry is mainly composed of SMEs, representing 95% of the sector, which face numerous obstacles. Among the main obstacles we can mention: competition with large groups while searching for collaboration with them, stronger regulatory environments, the need of integrating diverse technologies in their products, etc.
In order to overcome these barriers, the Medtech Alliance aims to build a strong mutual understanding among the 4 clusters by identifying their assets and synergies in order to strengthen their collaboration. In this respect, 4 cluster study visits are planned in the next months, as well as working groups involving SMEs to assess their internationalisation needs and to identify the two most relevant target markets. To better address the foreign markets that will be selected, a series of intelligence and training actions dedicated to SMEs will be performed.
Based on all these activities, the partners will have the necessary information to develop a common sound and realistic internationalisation strategy to provide added value for the SMEs as well as for the competitiveness of the Medtech sector in Europe.
Work Package 1. Partnership building and identification of assets and synergies (wp-leader Biowin)
It is dedicated to partnership building and identification of common opportunities through the identification of common needs as the starting point of the project. All the four partners have a long operating history and possess an internationalization strategy; however, they have identified the necessity to join forces and work together, in order to reach an important critical mass. The project partners will get to know in details the assets, values and services provided by the other clusters of the consortium, their internationalization activities as well as their technological and scientific competences.
Each partner will map its own competences and assets, with particular focus to those dedicated to internationalization, and share the results with the other partners. To foster mutual learning of the different Medtech ecosystem and create bonds of trust and share best practices in the internationalization area, four study visits will be organized within the cluster consortium.
Finally, internationalization needs of the clusters’SMEs will be assessed, leading to the identification of two non-European target countries.
Work Package 2. Training activities and fact-finding missions (wp-leader LifeScience Nord)
Following the outcomes of the cluster competencies mapping, of the on-site cluster study visits and of the assessment of common SMEs’ internationalization needs, and having identified the target countries, the cluster consortium will have the necessary information to perform a targeted series of intelligence and training actions to prepare the clusters and the SMEs towards market needs.
Market studies will be commissioned: they will include relevant information on the target countries concerning the healthcare market, the regulatory framework situation as well as the opportunities to address to optimize the SMEs competitiveness.
At the same time, foreign experts will be invited in order to support and train the cluster managers in the development of a common internationalization strategy and in the identification of peer support actors in the target countries. Foreign experts will also hold workshops/webinars which will help the SMEs to identify business opportunities in the target countries, as well as learn about various aspects of the foreign markets (e.g. business culture, regulatory environment, etc.).
Finally, following the phase of theoretical identification and analysis of the target market, two fact-finding mission towards will be organized in order to build institutional and personal networks within the target countries.
Work Package 3. Joint internationalization strategy definition (wp-leader LifeScience Nord)
Capitalizing on the results of the WP1 and WP2, in WP3 the partners will define a Joint Internationalization Strategy (JIS) with a shared strategic vision and common goals towards the chosen markets. In the preparation of the JIS the clusters’ associated SMEs will be actively involved and will help the consortium, with a design thinking approach, in defining common strategic lines.
Future tools and activities for clusters and companies will be defined in order to find the best solutions able to fit with the internationalization needs of the companies in the target markets. The strategy will include a partnership agreement with a long-term cooperation agenda, which will remain in place also after the end of the financed project, and a sustainability plan.
The partners will also develop an implementation roadmap containing an overview of the joint activities foreseen to be developed with a plan for implementation and a scoreboard of Key Performance Indicators (KPI) which will help each cluster to monitor the status of the operations.
Work Package 4. Meta-cluster marketing, communication and dissemination (wp-leader LyonbioPole)
Dedicated to dissemination and communication, WP4 will last during the whole project and is a transversal WP nourished by all the WPs and strengthening them in return. It will be articulated with the milestones and events of WP1, WP2 and WP3. Communication and dissemination activities will operate both at internal and external level in order to involve and mobilize each partner’s network and potential partners.
Work Package 5. Project management and monitoring activities (wp-leader bioPmed)
Dedicated to project management, WP5 will be essential for the project life and its structuring process, as it will enable a sound management by controlling the overall consistency between the planned activities and the achievements, making available at any time all the documents relevant to the project and controlling the operational figures reported by the participants and reminding deadlines.